Onocko-Campos Rosana Teresa, Passos Eduardo, Palombini Analice de Lima, dos Santos Deivisson Vianna Dantas, Stefanello Sabrina, Lamas Laura Gonçalves Martins, de Andrade Paula Milward, Borges Luana Ribeiro
Cien Saude Colet. 2013 Oct;18(10):2889-98. doi: 10.1590/s1413-81232013001000013.
In a context of high rates of medicalization of the population and in light of the scantly critical use of psychiatric medications in mental health services, this paper reports aspects of a qualitative study that had the opportunity to intervene in care practices in three major Brazilian cities. Following the principle of Brazilian Psychiatric Reform championing users' rights to participate in decisions about their treatment, the research intervened in psychosocial care centers (CAPS) seeking the empowerment of the users regarding the use of drugs in their therapeutic projects. Interviews were conducted and focus groups set up. From this recorded material, the paper analyzed some situations that, among other things, attested to the difficulty of avoiding the exercise of power over users via the administration of psychotropic drugs. Little dialogue about drugs, and the existence of stigmatization spaces where user rights are inhibited or "accepted with caution," was also detected in the services surveyed.
在人口医疗化程度较高且精神卫生服务中对精神科药物的批判性使用不足的背景下，本文报告了一项定性研究的相关方面，该研究有机会在巴西三个主要城市的护理实践中进行干预。遵循巴西精神科改革倡导用户参与治疗决策权利的原则，该研究在心理社会护理中心（CAPS）进行干预，寻求增强用户在其治疗方案中使用药物方面的权能。进行了访谈并设立了焦点小组。基于这些记录材料，本文分析了一些情况，这些情况除其他外证明了通过使用精神药物对用户行使权力的困难。在所调查的服务中还发现，关于药物的对话很少，并且存在抑制或“谨慎接受”用户权利的污名化空间。
